Breath profiles by electronic nose correlate with systemic markers but not ozone response

Respiratory Medicine

Volumn 105, Issue 9, 2011, Pages 1352-1363

  Biller, Heike ^a   Holz, Olaf ^a   Windt, Horst ^a   Koch, Wolfgang ^a   Müller, Meike ^a   Jörres, Rudolf A ^b   Krug, Norbert ^a   Hohlfeld, Jens M ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Electronic nose; Non invasive monitoring; Ozone challenge; Volatile organic compounds

Indexed keywords

NITRIC OXIDE; OZONE;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BLOOD SAMPLING; DOUBLE BLIND PROCEDURE; ELECTRONIC NOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; EXHALATION; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG; MALE; NEUTROPHIL COUNT; NON INVASIVE PROCEDURE; OXIDATIVE STRESS; PERMEABILITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SENSOR; SPIROMETRY; SPUTUM CULTURE; VEIN PUNCTURE;

ADULT; ASTHMA; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; BREATH TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXHALATION; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE; OZONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; VOLATILE ORGANIC COMPOUNDS;

EID: 79960471595     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.03.002     Document Type: Article

References (30)

1. Revised GINA guidelines 2006: global initiative for asthma. National Institutes of Health, National Heart, Lung and Blood Institute. NIH Publication No. 02-3659; 2002.
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256 1276 For the update of definitions (2004) see: http://www.goldcopd. com/
3. R. Djukanovic, P.J. Sterk, J.V. Fahy, and F.E. Hargreave Standardised methodology of sputum induction and processing Eur Respir J 20 2002 1S 55S
4. C. Taube, O. Holz, M. Mücke, R.A. Jörres, and H. Magnussen Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 164 2001 1810 1815 (Pubitemid 33152312)
5. D.R. Taylor, M.W. Pijnenburg, A.D. Smith, and J.C. De Jongste Exhaled nitric oxide measurements: clinical application and interpretation Thorax 61 2006 817 827 (Pubitemid 44369409)
6. I. Horvath, J. Hunt, P.J. Barnes, K. Alving, A. Antczak, and E. Baraldi Exhaled breath condensate: methodological recommendations and unresolved questions Eur Respir J 26 2005 523 548 (Pubitemid 41264218)
7. G. Peng, M. Hakim, Y.Y. Broza, S. Billan, R. Abdah-Bortnyak, and A. Kuten Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors Br J Cancer 103 2010 542 551
8. N. Fens, A.H. Zwinderman, M.P. van der Schee, S.B. de Nijs, E. Dijkers, and A.C. Roldaan Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma Am J Respir Crit Care Med 180 2009 1076 1082
9. P. Montuschi, M. Santonico, C. Mondino, G. Pennazza, G. Mantini, and E. Martinelli Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma Chest 137 2010 790 796
10. R.A. Jörres, O. Holz, W. Zachgo, P. Timm, S. Koschyk, and B. Müller The effect of repeated ozone exposures on inflammatory markers in bronchoalveolar lavage fluid and mucosal biopsies Am J Respir Crit Care Med 161 2000 1855 1861 (Pubitemid 30418120)
11. O. Holz, R. Tal-Singer, F. Kanniess, K.J. Simpson, A. Gibson, and R.S. Vessey Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development J Clin Pharmacol 45 2005 498 503 (Pubitemid 40562939)
12. N.E. Alexis, J.C. Lay, A. Haczku, H. Gong, W. Linn, and M.J. Hazucha Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers Environ Health Perspect 116 2008 799 805 (Pubitemid 351943937)
13. O. Holz, S. Khalilieh, A. Ludwig-Sengpiel, H. Watz, P. Stryszak, and P. Soni SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Eur Respir J 35 2010 564 570
14. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children, 2005 Am J Respir Crit Care Med 171 2005 912 930
15. O. Holz, R.A. Jörres, S. Koschyk, P. Speckin, L. Welker, and H. Magnussen Changes in sputum composition during sputum induction in healthy and asthmatic subjects Clin Exp Allergy 28 1998 284 292 (Pubitemid 28125912)
16. O. Holz, R.A. Jörres, P. Timm, M. Mücke, K. Richter, and S. Koschyk Ozone-induced airway inflammatory changes differ between individuals and are reproducible Am J Respir Crit Care Med 159 1999 776 784 (Pubitemid 29137773)
17. W.F. McDonnell, D.H. Horstman, S. Abdul-Salaam, and D.E. House Reproducibility of individual responses to ozone exposure Am Rev Respir Dis 131 1985 36 40 (Pubitemid 15161960)
18. H.W. de Gouw, J. Hendriks, A.M. Woltman, I.M. Twiss, and P.J. Sterk Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma Am J Respir Crit Care Med 158 1998 315 319 (Pubitemid 28337197)
19. J. Beier, K.M. Beeh, O. Kornmann, and R. Buhl Sputum induction leads to a decrease of exhaled nitric oxide unrelated to airflow Eur Respir J 22 2003 354 357 (Pubitemid 36987010)
20. M. Ichinose, H. Sugiura, S. Yamagata, A. Koarai, M. Tomaki, and H. Ogawa Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways Eur Respir J 22 2003 457 461 (Pubitemid 37098926)
21. C. Wyse, A. Cathcart, R. Sutherland, S. Ward, L. McMillan, and G. Gibson Effect of maximal dynamic exercise on exhaled ethane and carbon monoxide levels in human, equine, and canine athletes Comp Biochem Physiol A Mol Integr Physiol 141 2005 239 246 (Pubitemid 40965758)
22. J. King, P. Mochalski, A. Kupferthaler, K. Unterkofler, H. Koc, and W. Filipiak Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study Physiol Meas 31 2010 1169 1184
23. D.A. Lomas, E.K. Silverman, L.D. Edwards, N.W. Locantore, B.E. Miller, and D.H. Horstman Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD Eur Respir J 34 2009 95 102
24. K. Sawyer, J.M. Samet, A.J. Ghio, J.D. Pleil, and M.C. Madden Responses measured in the exhaled breath of human volunteers acutely exposed to ozone and diesel exhaust J Breath Res 2 2008 1 9
25. C. Turner, P. Spanel, and D. Smith A longitudinal study of methanol in the exhaled breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS Physiol Meas 27 2006 637 648 (Pubitemid 43841053)
26. M. Barker, M. Hengst, J. Schmid, H.J. Buers, B. Mittermaier, and D. Klemp Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Eur Respir J 27 2006 929 936 (Pubitemid 44911105)
27. B. Buszewski, M. Kesy, T. Ligor, and A. Amann Human exhaled air analytics: biomarkers of diseases Biomed Chromatogr 21 2007 553 566 (Pubitemid 46937852)
28. S. Dragonieri, J.T. Annema, R. Schot, M.P. van der Schee, A. Spanevello, and P. Carratu An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD Lung Cancer 64 2009 166 170
29. ® bags for breath-gas sampling and analysis J Breath Res 2 2008 1 19
30. S. Dragonieri, R. Schot, B.J. Mertens, S. Le Cessie, S.A. Gauw, and A. Spanevello An electronic nose in the discrimination of patients with asthma and controls J Allergy Clin Immunol 120 2007 856 862 (Pubitemid 47542280)